In-hospital fatality and venous thromboembolism during the first and second COVID-19 waves at a center opting for standard-dose thromboprophylaxis.
作者信息
Mumoli Nicola, Conte Giulia, Cei Marco, Vitale Josè, Capra Riccardo, Rotiroti Giuseppe, Porta Cesare, Monolo Davide, Colombo Alessandra, Mazzone Antonino, Kucher Nils, Konstantinides Stavros V, Dentali Francesco, Barco Stefano
机构信息
Department of Internal Medicine, Magenta Hospital, Magenta, Italy.
Department of Internal Medicine, Magenta Hospital, Magenta, Italy.
出版信息
Thromb Res. 2021 Jul;203:82-84. doi: 10.1016/j.thromres.2021.04.026. Epub 2021 May 1.
Abstract
摘要
相似文献
1
In-hospital fatality and venous thromboembolism during the first and second COVID-19 waves at a center opting for standard-dose thromboprophylaxis.在一家选择标准剂量血栓预防措施的中心，第一波和第二波新冠疫情期间的院内死亡率和静脉血栓栓塞情况。
Thromb Res. 2021 Jul;203:82-84. doi: 10.1016/j.thromres.2021.04.026. Epub 2021 May 1.
2
Intermediate dose thromboprophylaxis in SARS-CoV-2 related venous thrombo embolism.严重急性呼吸综合征冠状病毒2型（SARS-CoV-2）相关静脉血栓栓塞症的中等剂量血栓预防
Eur J Intern Med. 2021 Jun;88:141-143. doi: 10.1016/j.ejim.2021.03.025. Epub 2021 Mar 26.
3
The Incidence of Venous Thromboembolism in Critically Ill Patients with SARS-CoV-2 Infection Compared with Critically Ill Influenza and Community-Acquired Pneumonia Patients: A Retrospective Chart Review.严重急性呼吸综合征冠状病毒 2 感染的危重病患者与严重流感和社区获得性肺炎患者的静脉血栓栓塞发生率：一项回顾性图表回顾。
Med Sci (Basel). 2022 Jun 8;10(2):30. doi: 10.3390/medsci10020030.
4
Intensified thromboprophylaxis in COVID-19 critically ill patients: Is it enough?COVID-19重症患者强化血栓预防：这足够了吗？
J Infect. 2021 May;82(5):e20-e22. doi: 10.1016/j.jinf.2021.02.003. Epub 2021 Feb 5.
5
Pulmonary Embolism Prophylaxis in Patients With COVID-19: An Emerging Issue.COVID-19 患者的肺栓塞预防：一个新出现的问题。
Heart Lung Circ. 2021 Oct;30(10):1435-1441. doi: 10.1016/j.hlc.2021.04.018. Epub 2021 May 12.
6
Thromboprophylaxis and anticoagulation for inpatients with COVID-19 in 2022 and beyond.2022年及以后COVID-19住院患者的血栓预防与抗凝治疗
Clin Microbiol Infect. 2022 Sep;28(9):1184-1186. doi: 10.1016/j.cmi.2022.05.027. Epub 2022 May 29.
7
Venous thromboembolism in COVID-19: systematic review of reported risks and current guidelines.COVID-19 相关静脉血栓栓塞症：已报告风险和现行指南的系统综述。
Swiss Med Wkly. 2020 Jun 21;150:w20301. doi: 10.4414/smw.2020.20301. eCollection 2020 Jun 15.
8
Risks of deep vein thrombosis, pulmonary embolism, and bleeding after covid-19: nationwide self-controlled cases series and matched cohort study.新冠肺炎后深静脉血栓形成、肺栓塞和出血的风险：全国性自身对照病例系列和匹配队列研究。
BMJ. 2022 Apr 6;377:e069590. doi: 10.1136/bmj-2021-069590.
9
Pulmonary Embolism or Pulmonary Thrombosis in COVID-19? Is the Recommendation to Use High-Dose Heparin for Thromboprophylaxis Justified?新冠病毒感染中的肺栓塞或肺血栓形成？使用高剂量肝素进行血栓预防的建议是否合理？
Thromb Haemost. 2020 Aug;120(8):1230-1232. doi: 10.1055/s-0040-1712097. Epub 2020 Apr 29.
10
Extensive deep vein thrombosis and pulmonary embolism as a unique clinical manifestation of COVID-19 in a young healthy patient.新冠肺炎在年轻健康患者中以广泛的深静脉血栓和肺栓塞为独特临床表现。
Vascular. 2022 Oct;30(5):1013-1016. doi: 10.1177/17085381211040989. Epub 2021 Aug 20.
引用本文的文献
1
Incidence of Venous Thromboembolism in Hospitalized COVID-19 Patients Receiving Thromboprophylaxis.接受血栓预防治疗的住院COVID-19患者静脉血栓栓塞的发生率。
J Hematol. 2022 Oct;11(5):167-175. doi: 10.14740/jh1036. Epub 2022 Oct 31.
2
Venous thromboembolism in COVID-19: A meta-summary of cases.COVID-19 相关静脉血栓栓塞症：病例汇总分析。
Saudi Med J. 2022 Sep;43(9):979-990. doi: 10.15537/smj.2022.43.9.20220316.
3
Empiric Anticoagulation Therapy in Hospitalized COVID-19 Patients: An Evaluation of Bleeding Risk Scores Performances in Predicting Bleeding Events.住院COVID-19患者的经验性抗凝治疗：评估出血风险评分在预测出血事件中的表现
J Clin Med. 2022 Aug 24;11(17):4965. doi: 10.3390/jcm11174965.
4
Deaths related to pulmonary embolism and cardiovascular events before and during the 2020 COVID-19 pandemic: An epidemiological analysis of data from an Italian high-risk area.2020 年 COVID-19 大流行前后与肺栓塞和心血管事件相关的死亡：来自意大利高危地区数据的流行病学分析。
Thromb Res. 2022 Apr;212:44-50. doi: 10.1016/j.thromres.2022.02.008. Epub 2022 Feb 20.
5
Association between Early Absolute Neutrophil Count and Level of D-Dimer among Patients with COVID-19 Infection in Central Taiwan.台湾中部地区新冠肺炎感染患者早期绝对中性粒细胞计数与D-二聚体水平之间的关联
J Clin Med. 2021 Aug 30;10(17):3891. doi: 10.3390/jcm10173891.
6
American Society of Hematology living guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19: May 2021 update on the use of intermediate-intensity anticoagulation in critically ill patients.美国血液学会关于 COVID-19 患者血栓预防中抗凝治疗的临床实践指南：2021 年 5 月关于危重症患者中强度抗凝治疗的更新。
Blood Adv. 2021 Oct 26;5(20):3951-3959. doi: 10.1182/bloodadvances.2021005493.
本文引用的文献
1
Incidence of thrombotic complications and overall survival in hospitalized patients with COVID-19 in the second and first wave.COVID-19 第二波和第一波住院患者的血栓并发症发生率和总生存率。
Thromb Res. 2021 Mar;199:143-148. doi: 10.1016/j.thromres.2020.12.019. Epub 2020 Dec 30.
2
Incidence of symptomatic venous thromboembolism following hospitalization for coronavirus disease 2019: Prospective results from a multi-center study.新冠肺炎住院患者症状性静脉血栓栓塞症的发生率：一项多中心前瞻性研究的结果。
Thromb Res. 2021 Feb;198:135-138. doi: 10.1016/j.thromres.2020.12.001. Epub 2020 Dec 11.
3
Severe Acute Respiratory Syndrome Coronavirus 2 Lethality Did not Change Over Time in Two Italian Provinces.严重急性呼吸综合征冠状病毒2在意大利两个省份的致死率并未随时间变化。
Open Forum Infect Dis. 2020 Nov 12;7(12):ofaa556. doi: 10.1093/ofid/ofaa556. eCollection 2020 Dec.
4
Increased interest in acute pulmonary embolism in Italy during the COVID-19 pandemic: a google trends-based analysis.意大利在新冠疫情期间对急性肺栓塞的关注度增加：基于谷歌趋势的分析
J Thromb Thrombolysis. 2021 Jul;52(1):92-94. doi: 10.1007/s11239-020-02336-9. Epub 2020 Nov 11.
5
Incidence of acute pulmonary embolism in COVID-19 patients: Systematic review and meta-analysis.新型冠状病毒肺炎患者急性肺栓塞的发生率：系统评价和荟萃分析。
Eur J Intern Med. 2020 Dec;82:29-37. doi: 10.1016/j.ejim.2020.09.006. Epub 2020 Sep 17.
6
Intravenous methylprednisolone pulse as a treatment for hospitalised severe COVID-19 patients: results from a randomised controlled clinical trial.静脉注射甲泼尼龙脉冲治疗住院的严重 COVID-19 患者：一项随机对照临床试验的结果。
Eur Respir J. 2020 Dec 24;56(6). doi: 10.1183/13993003.02808-2020. Print 2020 Dec.
7
Enoxaparin for primary thromboprophylaxis in ambulatory patients with coronavirus disease-2019 (the OVID study): a structured summary of a study protocol for a randomized controlled trial.依诺肝素用于伴有 2019 冠状病毒病的门诊患者的一级血栓预防（OVID 研究）：一项随机对照试验研究方案的结构化总结。
Trials. 2020 Sep 9;21(1):770. doi: 10.1186/s13063-020-04678-4.
8
Anticoagulant interventions in hospitalized patients with COVID-19: A scoping review of randomized controlled trials and call for international collaboration.COVID-19 住院患者的抗凝干预措施：随机对照试验的范围综述及国际合作呼吁。
J Thromb Haemost. 2020 Nov;18(11):2958-2967. doi: 10.1111/jth.15094. Epub 2020 Oct 1.
9
Dexamethasone in Hospitalized Patients with Covid-19.地塞米松在 COVID-19 住院患者中的应用。
N Engl J Med. 2021 Feb 25;384(8):693-704. doi: 10.1056/NEJMoa2021436. Epub 2020 Jul 17.
10
Venous thromboembolism in COVID-19: systematic review of reported risks and current guidelines.COVID-19 相关静脉血栓栓塞症：已报告风险和现行指南的系统综述。
Swiss Med Wkly. 2020 Jun 21;150:w20301. doi: 10.4414/smw.2020.20301. eCollection 2020 Jun 15.
Zotero 插件